BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 15983251)

  • 1. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
    van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
    Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
    Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
    Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein distribution and correlates among men and women with chronic coronary heart disease.
    Benderly M; Haim M; Boyko V; Tanne D; Behar S; Matas Z; Zimlichman R; Goldbourt U
    Cardiology; 2007; 107(4):345-53. PubMed ID: 17283424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
    Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
    Koenig W; Khuseyinova N; Baumert J; Thorand B; Loewel H; Chambless L; Meisinger C; Schneider A; Martin S; Kolb H; Herder C
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2745-51. PubMed ID: 17008587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia.
    Hung J; Knuiman MW; Divitini ML; Langton PE; Chapman CL; Beilby JP
    Heart Lung Circ; 2008 Apr; 17(2):90-5. PubMed ID: 17851127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population.
    Hung J; Knuiman MW; Divitini ML; Davis T; Beilby JP
    Am J Cardiol; 2008 Jan; 101(2):193-8. PubMed ID: 18178405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study.
    Straczek C; Ducimetiere P; Barberger-Gateau P; Helmer C; Ritchie K; Jouven X; Carcaillon L; Amouyel P; Tzourio C; Empana JP
    J Am Geriatr Soc; 2010 Jan; 58(1):129-35. PubMed ID: 20002508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease.
    Khor LL; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Maycock CA; Anderson JL;
    Am J Med; 2004 Nov; 117(9):657-64. PubMed ID: 15501203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.